Trek Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,702
Closed -$1.82M 559
2026
Q1
$1.82M Buy
3,702
+544
+17% +$295K 0.1% 183
2025
Q4
$1.83M Buy
3,158
+67
+2% +$37.9K 0.11% 179
2025
Q3
$1.5M Buy
3,091
+896
+41% +$417K 0.09% 198
2025
Q2
$890K Buy
2,195
+32
+1% +$13.4K 0.06% 213
2025
Q1
$1.08M Buy
2,163
+429
+25% +$232K 0.08% 177
2024
Q4
$902K Buy
1,734
+573
+49% +$315K 0.07% 204
2024
Q3
$718K Buy
1,161
+116
+11% +$68.7K 0.05% 208
2024
Q2
$578K Buy
1,045
+385
+58% +$221K 0.05% 218
2024
Q1
$384K Buy
+660
New +$370K 0.03% 259

Other funds holding TMO

Trek Financial's TMO Position: Q2 2026 in Review

Trek Financial sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 3,702 shares — an estimated $1.82M sold.

Trek Financial first reported a position in TMO in Q1 2024 and held it in 9 quarters. The position peaked at $1.83M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Trek Financial reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Trek Financial sold 3,702 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.82M.
  • Trek Financial first reported a position in Thermo Fisher Scientific in Q1 2024 and held it in 9 quarters.
  • Trek Financial's Thermo Fisher Scientific position peaked at $1.83M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Trek Financial's 13F filing for Q2 2026, filed 13 Aug 2026.